SHANGHAI,Nov. 4,2024-- HR Asia,the leading publication in the human resources industry,announces the winners of its prestigious HR Asia Best Companies to Work for in Asia 2024 - China awards. This yea
Nov 5, 2024
The automotive tool and accessory brand brings its newest and most powerful offroading essentials to the premier Las Vegas trade show.
Nov 5, 2024
ZUNYI,China,Nov. 3,2024-- On October 31,theZunyi Talk "China\'s Development: An Opportunity for a Colorful World" was held in Zunyi City,southwest China\'s Guizhou Province. The event was at
Nov 4, 2024
RIYADH,Saudi Arabia,Nov. 3,2024-- The Future Investment Initiative (FII) Institute wrapped up Day 3 of its 8th annual gathering in Riyadh,with an "Investment Day" under the theme of "In
Nov 4, 2024
PALO ALTO,Calif.,Nov. 4,2024--Branch,the leading linking and measurement partner for growth-focused teams,in collaboration with Martechvibe,is excited to announce the release of its latest report,The
Nov 4, 2024
SUZHOU,China,Nov. 4,2024-- A new UN publication on using smart technologies to plan and build fair and sustainable cities will launch at the World Urban Forum (WUF12). Authors of the book will present
Nov 4, 2024
SHANGHAI,Nov. 4,2024-- United Imaging Healthcare (SSE: 688271),a global leader in manufacturing advanced medical imaging and radiotherapy equipment,announced its financial results for the third quarte
Nov 4, 2024
Sophia,the local humanoid,shines at the Summit,sparking excitement for Hong Kong\'s smart city future.
Nov 1, 2024
SHENZHEN,China,Oct. 31,2024-- Following its introduction to the Chinese market in 2021,theFormnext brand has established itself as a trusted name in the country\'s additive manufacturing (AM) and indu
Nov 1, 2024
HONG KONG,Oct. 31,2024-- As the AI 2.0 era unfolds,investing in AI infrastructure has become crucial for the future growth of AI enterprises. During the Fireside Chat "AI Innovation in Action wi
Nov 1, 2024
CHENGDU,China,Oct. 31,2024-- The new drug application (NDA) (the "Application") based on the positive results from the pivotalphase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-
Nov 1, 2024
BOSTON,Oct. 31,2024-- In a remarkable development for cancer research,patients with advanced-stage cancer have benefited fromSUPLEXA,a personalized treatment that trains the patient\'s own immune cel
Nov 1, 2024
Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News
© Singapore Technology Information Privacy Policy Contact us